Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Hubner

Showing results (21-30 of 106) with videos related to

Pageof 11
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism|November 1, 2023
Choosing the best systemic treatment sequence for control of tumour growth in gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): What is the recent evidence?Maria Passhak, Mairéad G McNamara, Richard A Hubner, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 13, 2020
Impact on prognosis of early weight loss during palliative chemotherapy in patients diagnosed with advanced pancreatic cancerLindsay Carnie, Marc Abraham, Mairéad G McNamara, et al.
Current Oncology (Toronto, Ont.)|September 27, 2023
Current Evidence for Immune Checkpoint Inhibition in Advanced Hepatocellular CarcinomaVictoria Foy, Mairéad G McNamara, Juan W Valle, et al.
Expert Opinion on Investigational Drugs|August 23, 2021
Druggable molecular alterations in bile duct cancer: potential and current therapeutic applications in clinical trialsHéloïse Bourien, Angela Lamarca, Mairéad G McNamara, et al.
Cancer Treatment Reviews|August 2, 2020
Impact of high tumor mutational burden in solid tumors and challenges for biomarker applicationMairéad G McNamara, Timothy Jacobs, Angela Lamarca, et al.
Cancers|October 16, 2024
Antibody-Drug Conjugates and Their Potential in the Treatment of Patients with Biliary Tract CancerShaun Alexander, Umair Aleem, Timothy Jacobs, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 22, 2020
The cost-effectiveness of TheraSphere in patients with hepatocellular carcinoma who are eligible for transarterial embolizationDerek Manas, Jon K Bell, Stuart Mealing, et al.
Immunotherapy|April 3, 2023
Targeting PD-1/PD-L1 in biliary tract cancer: role and available dataReem D Mahmood, Kathryn Graham, Jack Gleeson, et al.
Expert Review of Anticancer Therapy|June 29, 2022
Use of the Rockwood Clinical Frailty Scale in patients with advanced hepatopancreaticobiliary malignanciesDinakshi Shah, Zainul Abedin Kapacee, Angela Lamarca, et al.
Neuroendocrinology|March 16, 2020
Liver Embolisation for Patients with Neuroendocrine Neoplasms: Systematic ReviewRahul Kanabar, Jorge Barriuso, Mairéad G McNamara, et al.
Pageof 11

Showing results (21-30 of 106) with videos related to

Sort By:
Pageof 11
Best Practice & Research. Clinical Endocrinology & Metabolism|November 1, 2023
Choosing the best systemic treatment sequence for control of tumour growth in gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): What is the recent evidence?Maria Passhak, Mairéad G McNamara, Richard A Hubner, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 13, 2020
Impact on prognosis of early weight loss during palliative chemotherapy in patients diagnosed with advanced pancreatic cancerLindsay Carnie, Marc Abraham, Mairéad G McNamara, et al.
Current Oncology (Toronto, Ont.)|September 27, 2023
Current Evidence for Immune Checkpoint Inhibition in Advanced Hepatocellular CarcinomaVictoria Foy, Mairéad G McNamara, Juan W Valle, et al.
Expert Opinion on Investigational Drugs|August 23, 2021
Druggable molecular alterations in bile duct cancer: potential and current therapeutic applications in clinical trialsHéloïse Bourien, Angela Lamarca, Mairéad G McNamara, et al.
Cancer Treatment Reviews|August 2, 2020
Impact of high tumor mutational burden in solid tumors and challenges for biomarker applicationMairéad G McNamara, Timothy Jacobs, Angela Lamarca, et al.
Cancers|October 16, 2024
Antibody-Drug Conjugates and Their Potential in the Treatment of Patients with Biliary Tract CancerShaun Alexander, Umair Aleem, Timothy Jacobs, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 22, 2020
The cost-effectiveness of TheraSphere in patients with hepatocellular carcinoma who are eligible for transarterial embolizationDerek Manas, Jon K Bell, Stuart Mealing, et al.
Immunotherapy|April 3, 2023
Targeting PD-1/PD-L1 in biliary tract cancer: role and available dataReem D Mahmood, Kathryn Graham, Jack Gleeson, et al.
Expert Review of Anticancer Therapy|June 29, 2022
Use of the Rockwood Clinical Frailty Scale in patients with advanced hepatopancreaticobiliary malignanciesDinakshi Shah, Zainul Abedin Kapacee, Angela Lamarca, et al.
Neuroendocrinology|March 16, 2020
Liver Embolisation for Patients with Neuroendocrine Neoplasms: Systematic ReviewRahul Kanabar, Jorge Barriuso, Mairéad G McNamara, et al.
Pageof 11